Skip to Content

Rule

New Animal Drugs; Change of Sponsor

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 67521

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule.

SUMMARY:

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for 12 approved new animal drug applications (NADAs) from A. H. Robins Co. to Fort Dodge Animal Health, Division of Wyeth.

DATES:

This rule is effective November 6, 2002.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Lonnie W. Luther, Center for Veterinary Medicine (HFV-104), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 301-827-8549, e-mail: lluther@cvm.fda.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

A. H. Robins Co., P.O. Box 518, Fort Dodge, IA 50501-0518, has informed FDA that it has transferred ownership of, and all rights and interest in, the following 12 approved NADAs to Fort Dodge Animal Health, Division of Wyeth, 800 Fifth St. NW., Fort Dodge, IA 50501:

NADA NumberProduct Name
034-879DOPRAM-V Injectable
038-838ROBAXIN-V Injectable
045-715ROBAXIN-V Tablets
091-065ROBIZONE-V
093-105ROBIZONE-V
098-640ROBIZONE Injectable 20%
101-777Robinul-V Injectable
106-111Telazol
136-651Guailaxin
141-003Derm-Otic Ointment
141-004Robamox-V
141-005Robamox-V Tablets

Accordingly, the agency is amending the regulations in 21 CFR 520.88b, 520.88f, 520.1380, 520.1720a, 522.775, 522.1066, 522.1085, 522.1380, 522.1720, 522.2470, and 524.1600a to reflect the transfer of ownership and to reflect current format.

Following this change of sponsorship, A. H. Robins Co. is no longer the sponsor of any approved application. Accordingly, 21 CFR 510.600(c) is being amended to remove the entries for A. H. Robins Co.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

Start List of Subjects

List of Subjects

21 CFR Part 510

  • Administrative practice and procedure
  • Animal drugs
  • Labeling
  • Reporting and recordkeeping requirements

21 CFR Parts 520, 522, and 524

  • Animal drugs
End List of Subjects Start Amendment Part

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, 522, and 524 are amended as follows:

End Amendment Part Start Part

PART 510—NEW ANIMAL DRUGS

End Part Start Amendment Part

1. The authority citation for 21 CFR part 510 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

End Authority
[Amended]
Start Amendment Part

2. Section 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications is amended in the table in paragraph (c)(1) by removing the entry for “A. H. Robins Co.” and in the table in paragraph (c)(2) by removing the entry for “000031”.

End Amendment Part Start Part

PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

3. The authority citation for 21 CFR part 520 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]
Start Amendment Part

4. Section 520.88b Amoxicillin trihydrate for oral suspension is amended in paragraph (c) by removing “000031 and 000093” and by adding in its place “000093 and 000856”.

End Amendment Part
[Amended]
Start Amendment Part

5. Section 520.88f Amoxicillin trihydrate tablets is amended in paragraph (b) by removing “000031 or 000093” and by adding in its place “000093 and 000856”.

End Amendment Part
[Amended]
Start Amendment Part

6. Section 520.1380 Methocarbamol tablets is amended in paragraph (c) by removing “000031” and by adding in its place “000856”.

End Amendment Part
[Amended]
Start Amendment Part

7. Section 520.1720a Phenylbutazone tablets and boluses is amended in paragraph (b)(3) by removing “000031”.

End Amendment Part Start Part

PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

8. The authority citation for 21 CFR part 522 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]
Start Amendment Part

9. Section 522.775 Doxapram hydrochloride injection is amended in paragraph (b) by removing “000031” and by adding in its place “000856”.

End Amendment Part
[Amended]
Start Amendment Part

10. Section 522.1066 Glycopyrrolate injection is amended in paragraph (b) by removing “000031” and by adding in its place “000856”.

End Amendment Part
[Amended]
Start Amendment Part

11. Section 522.1085 Guaifenesin sterile powder is amended in paragraph (b) by removing “No. 000031” and by adding in its place “Nos. 000856”.

End Amendment Part
[Amended]
Start Amendment Part

12. Section 522.1380 Methocarbamol injection is amended in paragraph (b) by removing “000031” and by adding in its place “No. 000856”.

End Amendment Part
[Amended]
Start Amendment Part

13. Section 522.1720 Phenylbutazone injection is amended in paragraph (b)(1) by removing “000031” and by numerically adding “000856”.

End Amendment Part
[Amended]
Start Amendment Part

14. Section 522.2470 Tiletamine hydrochloride and zolazepam hydrochloride for injection is amended in paragraph (b) by removing “000031” and by adding in its place “000856”.

End Amendment Part Start Part

PART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

15. The authority citation for 21 CFR part 524 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]
Start Amendment Part

16. Section 524.1600a Nystatin, neomycin, thiostrepton, and triamcinolone acetonide ointment is amended in paragraph (b) by removing “000031” and by numerically adding “000856”.

End Amendment Part Start Signature

Dated: October 28, 2002.

Andrew J. Beaulieu,

Acting Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

End Signature End Supplemental Information

[FR Doc. 02-28156 Filed 11-5-02; 8:45 am]

BILLING CODE 4160-01-S